Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Pavlovic

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Asian Journal of Urology|December 22, 2017
Stents for malignant ureteral obstructionKristina Pavlovic, Dirk Lange, Ben H Chew
Bioinformatics (Oxford, England)|May 16, 2017
DIRECTION: a machine learning framework for predicting and characterizing DNA methylation and hydroxymethylation in mammalian genomesMilos Pavlovic, Pradipta Ray, Kristina Pavlovic, et al.
Frontiers in Immunology|October 29, 2020
Using Gene Editing Approaches to Fine-Tune the Immune SystemKristina Pavlovic, María Tristán-Manzano, Noelia Maldonado-Pérez, et al.
Molecular Therapy. Nucleic Acids|May 1, 2023
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cellsMaría Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, et al.
Frontiers in Immunology|October 24, 2022
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphomaNoelia Maldonado-Pérez, María Tristán-Manzano, Pedro Justicia-Lirio, et al.
Molecular Therapy Oncolytics|June 13, 2022
Physiological lentiviral vectors for the generation of improved CAR-T cellsMaría Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, et al.
Molecular Therapy Oncolytics|August 3, 2022
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cellsMaría Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, et al.
Molecular Therapy. Nucleic Acids|December 6, 2024
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomasPedro Justicia-Lirio, María Tristán-Manzano, Noelia Maldonado-Pérez, et al.
Frontiers in Immunology|June 13, 2024
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptomeKristina Pavlovic, MDolores Carmona-Luque, Giulia I Corsi, et al.
Molecular Therapy. Nucleic Acids|February 24, 2025
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working GroupAlessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Asian Journal of Urology|December 22, 2017
Stents for malignant ureteral obstructionKristina Pavlovic, Dirk Lange, Ben H Chew
Bioinformatics (Oxford, England)|May 16, 2017
DIRECTION: a machine learning framework for predicting and characterizing DNA methylation and hydroxymethylation in mammalian genomesMilos Pavlovic, Pradipta Ray, Kristina Pavlovic, et al.
Frontiers in Immunology|October 29, 2020
Using Gene Editing Approaches to Fine-Tune the Immune SystemKristina Pavlovic, María Tristán-Manzano, Noelia Maldonado-Pérez, et al.
Molecular Therapy. Nucleic Acids|May 1, 2023
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cellsMaría Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, et al.
Frontiers in Immunology|October 24, 2022
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphomaNoelia Maldonado-Pérez, María Tristán-Manzano, Pedro Justicia-Lirio, et al.
Molecular Therapy Oncolytics|June 13, 2022
Physiological lentiviral vectors for the generation of improved CAR-T cellsMaría Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, et al.
Molecular Therapy Oncolytics|August 3, 2022
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cellsMaría Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, et al.
Molecular Therapy. Nucleic Acids|December 6, 2024
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomasPedro Justicia-Lirio, María Tristán-Manzano, Noelia Maldonado-Pérez, et al.
Frontiers in Immunology|June 13, 2024
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptomeKristina Pavlovic, MDolores Carmona-Luque, Giulia I Corsi, et al.
Molecular Therapy. Nucleic Acids|February 24, 2025
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working GroupAlessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Pageof 1